Pacific Biosciences of California Inc (MEX:PACB)
MXN 27.5 (0%) Market Cap: 9.44 Bil Enterprise Value: 16.93 Bil PE Ratio: 0 PB Ratio: 206.25 GF Score: 53/100

Pacific Biosciences of California Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2026 / 06:30PM GMT
Release Date Price: MXN27.99
Max Marks
JPMorgan - Analyst

Hello, everyone, and welcome to the 44th Annual JPMorgan Healthcare Conference. My name is Max Marks, and I'm an associate on the JPM Healthcare Investment Banking team. And it is my pleasure to introduce Christian Henry, CEO of PacBio.

Christian Henry
Pacific Biosciences of California Inc - President, Chief Executive Officer, Director

Thank you. Thank you, Max. Thank you to the JPMorgan team for the opportunity to present today. As Max said, my name is Christian Henry, and I'm the President and Chief Executive Officer of PacBio. I'd also like to thank all of you in the room today and on listening online, for your time and your attention.

Before we dive in, I am going to remind everyone that we may be making some forward-looking statements, and I would ask for you to take a look at our SEC filings on our webpage for more details on the risks and uncertainties that are related to our business.

But with that, let's get started. Our mission is enabling the promise of genomics to better human health, and we achieve

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot